USPTO serial 79412046
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
FUJIFILM Diosynth Biotechnologies UK Limited
GB
Other trademarks owned by FUJIFILM Diosynth Biotechnologies UK Limited
FUJIFILM Diosynth Biotechnologies UK Limited
GB
Other trademarks owned by FUJIFILM Diosynth Biotechnologies UK Limited
FUJIFILM Diosynth Biotechnologies UK Limited
GB
Other trademarks owned by FUJIFILM Diosynth Biotechnologies UK Limited
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Allisen Pawlenty
Allisen Pawlenty Coates IP3057 Nutley St. #801Fairfax, VA 22031United States| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry and science; cell cultures used in industry and science; biological preparations for use in science; biological preparations for use in cell cultures, other than for medical or veterinary purposes; proteins for industrial use; microbial preparations being chemicals for industry; cultures of micro-organisms other than for medical or veterinary use; chemical reagents, other than for medical or veterinary purpose; organic chemicals for use in science, namely genes being DNA sequences; plasmids being small independently replicating pieces of DNA and vectors being small independently replicating pieces of DNA that can transfer DNA sequences, being chemicals for use in science; cell culture reagents for scientific and research use; media for cell culture for use in the biotechnological industry, other than for medical or veterinary use; chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes. | ACTIVE | — |
| 040 | Processing and manufacturing of chemicals and proteins; custom manufacture of chemicals and proteins for use in biotechnology and pharmaceuticals; manufacture, processing and production of scientific and industrial products, namely, recombinant proteins for use in the biotechnology industries to the order and specification of others; custom processing and manufacturing services of chemicals and proteins; custom processing and manufacturing of biological products; custom manufacture of biopharmaceuticals; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; cell culture manufacturing services for others; custom manufacture of biologics; information, advice and consultancy in relation to all the aforesaid. | ACTIVE | — |
| 042 | Scientific, industrial and technical research in the fields of biomanufacturing, bioprocessing, biopharmaceuticals and pharmaceuticals; scientific analysis in the fields of biomanufacturing, bioprocessing, biopharmaceuticals and pharmaceuticals; technological analysis services in the fields of biomanufacturing, bioprocessing, biopharmaceuticals and pharmaceuticals; scientific research and development; industrial process development in the fields of biomanufacturing, bioprocessing, biopharmaceuticals and pharmaceuticals; industrial design services; provision of facilities for scientific, industrial and technical research and development in the fields of biotechnology, bioprocessing, biopharmaceuticals and pharmaceuticals; research and development of scientific, industrial and technical products; technical project studies in the fields of biotechnology, bioprocessing, biopharmaceuticals and pharmaceuticals; testing of scientific, industrial and technical products in the fields of biotechnology, bioprocessing, biopharmaceuticals and pharmaceuticals; scientific research, industrial research in the fields of biotechnology, bioprocessing, biopharmaceuticals and pharmaceuticals and technical product research and development services in the field of biotechnology; development of processes for the use in the manufacture of biotechnology products; technical project studies in the fields of biotechnology, bioprocessing, biopharmaceuticals and pharmaceuticals; biotechnology product testing services; research and consultancy in the field of biotechnology; research and development in the pharmaceutical and biotechnology industry; development of processes for use in the manufacture of pharmaceutical and biological products; biopharmaceutical product development; design and development of manufacturing processes in the field of biopharmaceuticals; development of chemicals for use in the manufacture of biotechnology products and pharmaceuticals; preparation of biological samples for analysis in research laboratories; information, advice and consultancy in relation to all the aforesaid. | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 28, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 28, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 11, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 11, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 10, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 10, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 7, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 28, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 29, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 28, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 28, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 9, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 9, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 3, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 5, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 17, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 16, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 16, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 26, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 10, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 10, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 12, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 12, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 12, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 12, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 6, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 5, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 13, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 13, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 12, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |